Swiss CDMO specializing in formulation, analytical and process development, sterile manufacturing (fill and finish), and testing of injectable medicines. First CDMO in the pharmaceutical industry for injectables to be B Corp certified. Operates from Basel and Visp, Switzerland. Opened new VIVA2 facility with expanded sterile manufacturing lines. QC laboratories approved by both Swissmedic/RHI and FDA. Partners with BD on Libertas wearable injector commercialization. Supports biologics, small molecules, and RNA therapeutics.
Sterile injectable formulation and fill/finish, drug/device integration, lyophilization, molecule selection and characterization, packaging and device characterization, analytical development, process transfer and validation, stability and pre-clinical supplies, B Corp sustainability.
1 site worldwide
No reviews available yet.
No documents available.